$35 insulin caps for Medicare patients is not enough: advocates want price caps across the board
The sky-high cost of insulin is causing adults in the U.S. with diabetes to ration their medication. According to the American Diabetes Association (ADA), people with Type 1 diabetes need about two-to-three vials per month, which could total up to $1,000 or more. For those working to make ends meet, paying up to $300 a vial is near impossible, pushing people to either take less…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
AM Best Revises the Outlooks to Stable for Northern Mutual Insurance Company
AM Best Affirms Credit Ratings of XL Bermuda Ltd and Its Subsidiaries
Advisor News
- Flexibility is the future of employee financial wellness benefits
- Bill aims to boost access to work retirement plans for millions of Americans
- A new era of advisor support for caregiving
- Millennial Dilemma: Home ownership or retirement security?
- How OBBBA is a once-in-a-career window
More Advisor NewsAnnuity News
- 2025 Top 5 Annuity Stories: Lawsuits, layoffs and Brighthouse sale rumors
- An Application for the Trademark “DYNAMIC RETIREMENT MANAGER” Has Been Filed by Great-West Life & Annuity Insurance Company: Great-West Life & Annuity Insurance Company
- Product understanding will drive the future of insurance
- Prudential launches FlexGuard 2.0 RILA
- Lincoln Financial Introduces First Capital Group ETF Strategy for Fixed Indexed Annuities
More Annuity NewsHealth/Employee Benefits News
Life Insurance News
- Private placement securities continue to be attractive to insurers
- Inszone Insurance Services Expands Benefits Department in Michigan with Acquisition of Voyage Benefits, LLC
- Affordability pressures are reshaping pricing, products and strategy for 2026
- How the life insurance industry can reach the social media generations
- Judge rules against loosening receivership over Greg Lindberg finances
More Life Insurance News